| |
| |
|
| Insider
Information: |
Krognes Steve E. |
| Relationship: |
Director |
| City: |
Burlingame |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
50,734 |
|
|
Indirect Shares
|
850,000 |
|
|
| Direct
Value |
$949,660 |
|
|
|
Indirect Value
|
$17,051,000 |
|
|
| Total
Shares |
900,734 |
|
|
| Total
Value |
$18,000,660 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
14
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 38.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Director |
2024-04-01 |
47,341 |
2024-04-01 |
850,000 |
Premium* |
|
|
Guardant Health, Inc. |
GH |
Director |
2024-04-30 |
3,393 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2017-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
1,000,000 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,000 |
126,302 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
147,218 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2021-01-15 |
4 |
AS |
$70.10 |
$3,572,556 |
I/I |
(50,000) |
950,000 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2021-02-16 |
4 |
AS |
$64.27 |
$3,254,710 |
I/I |
(50,000) |
900,000 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2021-03-15 |
4 |
AS |
$61.16 |
$3,094,563 |
I/I |
(50,000) |
850,000 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2024-04-01 |
4 |
AS |
$20.50 |
$1,896,250 |
D/D |
(92,500) |
47,341 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2019-08-21 |
4 |
D |
$18.59 |
$36,745 |
D/D |
(1,977) |
1,003,666 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2020-08-21 |
4 |
D |
$32.87 |
$64,228 |
I/I |
(1,954) |
1,006,511 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
1,005,643 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2020-02-07 |
4/A |
OE |
$0.00 |
$0 |
D/D |
4,250 |
1,007,916 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2020-08-20 |
4 |
OE |
$0.00 |
$0 |
I/I |
5,643 |
1,008,465 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
CFO and Treasurer |
• – – |
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,250 |
14,427 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-07-19 |
4 |
OE |
$0.68 |
$42,500 |
D/D |
62,500 |
151,721 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,851 |
1,851 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-07-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,005 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,159 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
155 |
2,314 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,468 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,622 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
2,776 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
155 |
2,931 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-02-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,085 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,239 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
Director |
– • – |
2024-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
154 |
3,393 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
